NetSol Technologies Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
NetSol Technologies Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2023-09-30 | 2023-06-30 | 2022-06-30 | 2019-06-30 | 2014-09-30 | 2014-06-30 | 2012-09-30 | 2004-09-30 |
---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||
net income | 291,063 | -5,547,070 | -1,870,768 | 4,636,026 | -2,229,223 | -8,278,871 | 1,261,404 | |
adjustments to reconcile net income to net cash from operating activities: | ||||||||
depreciation and amortization | 530,786 | 725,069 | 942,602 | 1,072,898 | 2,382,340 | 3,861,554 | 1,300,152 | 481,865 |
provision (reversal) for bad debts | ||||||||
gain on sale of assets | -98 | -15,300 | ||||||
stock based compensation | 60,354 | 118,892 | 26,122 | 150,331 | ||||
changes in operating assets and liabilities: | ||||||||
accounts receivable | 4,608,881 | -5,005,084 | -2,265,015 | 2,412,578 | -5,723,728 | 4,701,101 | -214,527 | |
revenues in excess of billing | -1,478,386 | 1,273,981 | -887,722 | -3,901,977 | 133,763 | |||
other current assets | 92,686 | 490,623 | 416,021 | 328,781 | 479,340 | 71,985 | -826,311 | |
accounts payable and accrued expenses | 341,722 | -611,531 | 1,106,390 | 492,796 | -382,026 | -564,159 | ||
unearned revenue | -2,791,269 | 4,220,809 | -1,890,726 | 80,932 | ||||
net cash from operating activities | 1,663,619 | -555,048 | -2,465,329 | 5,188,592 | -481,025 | 3,308,051 | 2,898,831 | -1,062,227 |
capex | -371,630 | -64,379 | -928,349 | -136,256 | -1,031,128 | -3,652,473 | -1,457,134 | -213,990 |
free cash flows | 1,291,989 | -619,427 | -3,393,678 | 5,052,336 | -1,512,153 | -344,422 | 1,441,697 | -1,276,217 |
cash flows from investing activities: | ||||||||
purchases of property and equipment | -371,630 | -64,379 | -928,349 | -136,256 | -1,031,128 | -3,652,473 | -1,457,134 | -213,990 |
sales of property and equipment | 1,230 | 86,805 | 27,807 | 165,664 | 90,841 | 27,561 | 60,501 | 86,988 |
purchase of subsidiary shares | ||||||||
net cash from investing activities | -370,400 | 22,426 | -900,542 | -938,092 | -940,287 | -3,851,980 | -2,488,599 | |
cash flows from financing activities: | ||||||||
proceeds from the exercise of stock options and warrants | 0 | -1 | 252,900 | |||||
dividend paid by subsidiary to non-controlling interest | 0 | |||||||
proceeds from bank loans | 0 | 629,374 | -109,934 | 109,211 | 1,878,156 | 2,591,135 | ||
payments on finance lease obligations and loans - net | -44,474 | -140,519 | -224,640 | |||||
net cash from financing activities | -44,474 | -201,643 | -545,618 | -542,500 | 806,721 | -446,135 | 171,628 | 137,329 |
effect of exchange rate changes | -230,322 | 1,008,022 | -2,698,026 | -3,356,226 | -465,548 | 69,064 | ||
net increase in cash and cash equivalents | 1,018,423 | -6,609,515 | -921,000 | 420,181 | -666,311 | |||
cash and cash equivalents at beginning of the period | 15,533,254 | 0 | 0 | 0 | ||||
cash and cash equivalents at end of period | 16,551,677 | 273,757 | -6,609,515 | 351,774 | ||||
(gain) loss on sale of assets | 39,778 | -14,296 | ||||||
proceeds from the exercise of stock options | ||||||||
benefit from bad debts | 7,880 | 1,695,096 | 16,491 | 776,266 | ||||
share of net (gain) income from investment under equity method | ||||||||
net decrease in cash and cash equivalents | 273,757 | -1,080,139 | ||||||
goodwill impairment | ||||||||
impairment and share of net income from investment under equity method | ||||||||
loss on sale of assets | 23,333 | 11,052 | 620 | |||||
purchase of treasury stock | 0 | |||||||
purchase of subsidiary treasury stock | ||||||||
share of net income from investment under equity method | 1,703,899 | -1,528 | ||||||
gain on forgiveness of loan | ||||||||
investment in associates | ||||||||
accounts receivable - related party | -516,010 | -495,357 | ||||||
revenues in excess of billing - related party | -25,451 | |||||||
convertible note receivable - related party | -400,000 | |||||||
proceeds from exercise of subsidiary options | 0 | -20,782 | ||||||
fair market value of stock options | 0 | |||||||
impairment of assets | ||||||||
payments on capital lease obligations and loans - net | -181,621 | -2,591,334 | -2,270,018 | |||||
investment in wrld3d | ||||||||
purchase of subsidiary shares from open market | ||||||||
restricted cash | 2,438,844 | -33,490 | -1,571,442 | |||||
fair market value of warrants and stock options granted | 155,622 | 0 | 227,926 | 28,024 | ||||
stock issued for services | 290,162 | 259,193 | 29,670 | 25,745 | ||||
cash and cash equivalents, beginning of the period | 11,462,695 | 0 | ||||||
cash and cash equivalents, end of period | 10,382,556 | -921,000 | 204,850 | |||||
proceeds from sale of common stock | 850,000 | 220,000 | ||||||
investment in eegeo | ||||||||
purchase of non-controlling interest in subsidiary | ||||||||
investment | ||||||||
adjustments to reconcile net incometo net cash from operating activities: | ||||||||
dividend paid by subsidiary to non controlling interest | ||||||||
purchase of non-controlling interest in subsidiaries | 0 | |||||||
proceeds from stock subscription receivable | ||||||||
gain on sale of subsidiary | ||||||||
impairment of goodwill | ||||||||
sale of subsidiary | 0 | |||||||
increase in intangible assets | -227,068 | -1,091,966 | ||||||
unearned revenue - related party | ||||||||
share of net income (income) from investment under equity method | 175,151 | |||||||
accounts payable, accrued expenses and unearned revenue | 4,515,004 | |||||||
stock issued for interest on notes payable | 211,111 | |||||||
amortization of financing costs | ||||||||
accounts receivable-related party | ||||||||
revenue in excess of billing | 2,256,931 | |||||||
payment to common shareholders for fractional shares | ||||||||
supplemental disclosures: | ||||||||
cash paid during the period for: | ||||||||
interest | 104,763 | 102,198 | ||||||
taxes | 157,085 | 24,253 | ||||||
non-cash investing and financing activities: | ||||||||
stock issued for the payment of vendors | 0 | |||||||
stock issued for the conversion of convertible notes payable | ||||||||
stock issued for the conversion of interest payable | ||||||||
(gain) loss on sale of subsidiary | ||||||||
beneficial conversion feature | 367,744 | 37,500 | ||||||
increase in accounts receivable | -4,320,159 | |||||||
decrease in other current assets | 1,892,625 | |||||||
increase in accounts payable and accrued expenses | 1,942,654 | |||||||
investment under equity method | ||||||||
payment to common shareholders against fractional shares | -194 | |||||||
proceeds from convertible notes payable | ||||||||
payments on convertible notes payable | ||||||||
bank overdraft | 59,913 | |||||||
payments on capital lease obligations & loans - net | -1,160,684 | |||||||
effect of exchange rate changes in cash | -161,679 | 21,973 | ||||||
cash and cash equivalents, beginning of year | 7,599,607 | |||||||
cash and cash equivalents, end of year | 8,019,788 | |||||||
stock issued for the conversion of notes payable | 1,050,000 | |||||||
gain on settlement of finance lease | ||||||||
gain on settlement of lease abandonment provision | ||||||||
decrease (increase) in accounts receivable | ||||||||
increase in other current assets | ||||||||
decrease in accounts payable and accrued expenses | ||||||||
short-term investments held for sale | ||||||||
acquisition, net of cash acquired | ||||||||
dividend paid | ||||||||
payments on bank loans | ||||||||
increase/ decrease in accounts receivable | ||||||||
increase/ decrease in other current assets | ||||||||
increase/ decrease in accounts payable and accrued expenses | ||||||||
loss on foreign currency exchange transaction | ||||||||
(gain) on settlement of lease abandonment provision | ||||||||
redemption of preferred stock | ||||||||
investment in associate | ||||||||
stock issued for notes payable and related interest | ||||||||
addition to property and equipment | ||||||||
disposal of property and equipment | ||||||||
cash and cash equivalents, beginning of period | 871,161 | |||||||
adjustments to reconcile net income | ||||||||
to net cash from operating activities: | ||||||||
non controlling interest in subsidiary | ||||||||
gain on sale of subsidiary shares in pakistan | ||||||||
decrease in long-term assets | ||||||||
decrease/ increase in accounts payable and accrued expenses | ||||||||
payments of acquisition payable | ||||||||
purchase of subsidary stock in pakistan | ||||||||
proceeds from sale of subsidiary stock | ||||||||
loss on foreign currency exchange rates | ||||||||
share of net (income)/income from associates | ||||||||
(increase)/ decrease in accounts receivable | ||||||||
(increase)/ decrease in other current assets | ||||||||
increase/ (decrease) in accounts payable and accrued expenses | ||||||||
finance costs incurred for sale of common stock | ||||||||
loss on transaction of debt | ||||||||
stock issued for accrued interest on convertible notes | ||||||||
bad debt expense | ||||||||
minority interest in subsidiary | -15,068 | |||||||
net cash provided by/(used in) operating activities | ||||||||
dividend paid to preferred shareholders | ||||||||
benefit from uncollectible accounts | ||||||||
minority interest in subsidiary - restated in 2008 | ||||||||
stock based compensation expense | ||||||||
beneficial feature of convertible notes payable | ||||||||
increase(decrease)in accounts payable and accrued expenses | ||||||||
adjustments to reconcile net income to net cash | ||||||||
provided by operating activities: | ||||||||
purchase of subsidary shares | ||||||||
increase in restricted cash | ||||||||
net income from continuing operations | 34,358 | |||||||
used in operating activities: | ||||||||
gain on settlement of debt | -50,274 | |||||||
increase in assets: | ||||||||
decrease in liabilities: | ||||||||
purchases of certificates of deposit | ||||||||
proceeds from sale of certificates of deposit | 250,000 | |||||||
increase in intangible assets - development costs | -77,990 | |||||||
capital investments in minority interest of subsidiary | 191,606 | |||||||
proceeeds from sale of minority interest of subsidiary | ||||||||
net cash from provided by investing activities | 236,614 | |||||||
purchase of treasury shares | -51,704 | |||||||
proceeds from loans | ||||||||
payments on capital lease obligations & loans | -30,967 |
We provide you with 20 years of cash flow statements for NetSol Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NetSol Technologies stock. Explore the full financial landscape of NetSol Technologies stock with our expertly curated income statements.
The information provided in this report about NetSol Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.